Eric Wei's most recent trade in RxSight Inc was a trade of 35,168 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on Sept. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RxSight Inc | Mr. Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 15 Sep 2026 | 35,168 | 235,516 | - | 4.3 | 152,629 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 15 Sep 2026 | 35,168 | 0 | - | - | Stock Option (right to buy) | ||
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 16.33 per share. | 15 Sep 2026 | 6,000 | 265,262 | - | 16.3 | 97,980 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 125,000 | 0 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 95,000 | 0 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 93,984 | 93,984 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 92,200 | 0 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 87,437 | 0 | - | - | Stock option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 82,608 | 82,608 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 65,742 | 65,742 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 59,483 | 59,483 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 50,000 | 0 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | 05 Sep 2026 | 32,258 | 32,258 | - | - | Stock Option (right to buy) | ||
| Currenc Grp Inc | Mr. Eric Weinstein | Director | Grant, award, or other acquisition of securities at price $ 3.36 per share. | 02 Sep 2026 | 3,720 | 175,221 | - | 3.4 | 12,499 | Ordinary Shares |
| RxSight Inc | Mr. Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 5,370 | 202,389 | - | - | Common Stock | |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 31 Aug 2026 | 5,370 | 26,848 | - | - | Restricted Stock Unit | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 31 Aug 2026 | 2,041 | 200,348 | - | 7.0 | 14,205 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 19.19 per share. | 18 Aug 2026 | 7,000 | 259,262 | - | 19.2 | 134,358 | Common Stock |
| Currenc Grp Inc | Mr. Eric Weinstein | Director | Grant, award, or other acquisition of securities at price $ 3.19 per share. | 02 Jun 2026 | 3,918 | 171,501 | - | 3.2 | 12,498 | Ordinary Shares |
| GigaCloud Tech Inc (Class A) | Ms. Xiaoyang Erica Wei | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 12,000 | 31,000 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 14.53 per share. | 09 Mar 2026 | 7,000 | 252,262 | - | 14.5 | 101,700 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 27 Feb 2026 | 32,218 | 32,218 | - | - | Restricted Stock Unit | ||
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 18,575 | 245,262 | - | 0 | Common Stock | |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 15 Dec 2025 | 2,500 | 216,932 | - | 0.4 | 1,050 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 15 Dec 2025 | 2,500 | 214,432 | - | 0.4 | 1,025 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.36 per share. | 20 Nov 2025 | 1,000 | 211,932 | - | 0.4 | 365 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 20 Nov 2025 | 1,000 | 210,932 | - | 0.4 | 370 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 18 Nov 2025 | 7,500 | 205,432 | - | 0.4 | 3,025 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 18 Nov 2025 | 4,500 | 209,932 | - | 0.4 | 1,823 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 27,391,934 | 0 | - | 7.8 | 212,618,931 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 9,084,247 | 0 | - | 7.8 | 70,512,834 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 866,345 | 0 | - | 7.8 | 6,724,657 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 21.50 per share. | 04 Nov 2025 | 5,000 | 226,687 | - | 21.5 | 107,500 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 07 Aug 2025 | 22,005,957 | 27,391,934 | - | 9.9 | 217,231,805 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 07 Aug 2025 | 7,298,044 | 9,084,247 | - | 9.9 | 72,042,641 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 07 Aug 2025 | 695,999 | 866,345 | - | 9.9 | 6,870,554 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 02 Jun 2025 | 188,002 | 0 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.93 per share. | 02 Jun 2025 | 188,002 | 195,351 | - | 3.9 | 738,848 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.43 per share. | 27 May 2025 | 10,000 | 197,932 | - | 0.4 | 4,329 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, Chief Executive Officer | 23 May 2025 | 200,000 | 387,932 | - | - | Options (right to buy) | ||
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.08 per share. | 20 May 2025 | 22,005,957 | 49,397,891 | - | 9.1 | 199,814,090 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.08 per share. | 20 May 2025 | 7,298,044 | 16,382,291 | - | 9.1 | 66,266,240 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 9.08 per share. | 20 May 2025 | 695,999 | 1,562,344 | - | 9.1 | 6,319,671 | Common Stock |
| GigaCloud Tech Inc (Class A) | Ms. Xiaoyang Erica Wei | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 13,000 | 19,000 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 8.46 per share. | 06 Mar 2025 | 6,000 | 221,687 | - | 8.5 | 50,750 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 03 Mar 2025 | 30,808,368 | 71,403,848 | - | 10.3 | 318,096,400 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 03 Mar 2025 | 10,217,254 | 23,680,335 | - | 10.3 | 105,493,148 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 03 Mar 2025 | 974,378 | 2,258,343 | - | 10.3 | 10,060,453 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 27 Feb 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | ||
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 215,687 | - | 0 | Common Stock | |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 13 Dec 2024 | 2,500 | 187,932 | - | 0.8 | 2,097 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 20 Nov 2024 | 2,500 | 182,932 | - | 1.0 | 2,375 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 20 Nov 2024 | 2,500 | 185,432 | - | 0.9 | 2,250 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 9.21 per share. | 09 Sep 2024 | 5,000 | 195,239 | - | 9.2 | 46,050 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | See remarks | 07 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | ||
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.30 per share. | 01 Jul 2024 | 18,319,076 | 102,212,216 | - | 11.3 | 206,987,240 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.30 per share. | 01 Jul 2024 | 6,075,328 | 33,897,589 | - | 11.3 | 68,645,131 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.30 per share. | 01 Jul 2024 | 579,391 | 3,232,721 | - | 11.3 | 6,546,539 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 11 Jun 2024 | 4,438 | 180,432 | - | 1.1 | 4,926 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 11 Jun 2024 | 562 | 175,994 | - | 1.1 | 607 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 30,531,795 | 120,531,292 | - | 11.4 | 348,978,417 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 10,125,546 | 39,972,917 | - | 11.4 | 115,734,991 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 30 May 2024 | 965,651 | 3,812,112 | - | 11.4 | 11,037,391 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2024 | 127,446 | 142,446 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2024 | 47,793 | 190,239 | - | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 09 Apr 2024 | 12,212,720 | 151,063,087 | - | 11.6 | 141,362,234 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.57 per share. | 09 Apr 2024 | 4,050,218 | 50,098,463 | - | 11.6 | 46,881,273 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 09 Apr 2024 | 386,259 | 4,777,763 | - | 11.6 | 4,470,948 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 04 Apr 2024 | 600 | 175,032 | - | 2.0 | 1,176 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 04 Apr 2024 | 400 | 175,432 | - | 2.0 | 812 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 28 Mar 2024 | 3,408 | 173,332 | - | 1.9 | 6,612 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 28 Mar 2024 | 1,100 | 174,432 | - | 1.9 | 2,101 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Mr. Eric Stanton Weiss | Director | Purchase of securities on an exchange or from another person at price $ 3.03 per share. | 15 Mar 2024 | 15,000 | 15,000 | - | 3.0 | 45,396 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 30,195,949 | 163,275,807 | - | 11.3 | 342,120,102 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 10,014,164 | 54,148,681 | - | 11.3 | 113,460,478 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 955,026 | 5,164,022 | - | 11.3 | 10,820,445 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | 04 Mar 2024 | 92,200 | 92,200 | - | - | Stock Option (right to buy) | ||
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 01 Feb 2024 | 10,000 | 299,978 | - | 50.0 | 500,004 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 22 Jan 2024 | 10,000 | 309,978 | - | 48.0 | 480,006 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 09 Jan 2024 | 10,000 | 319,978 | - | 46 | 460,000 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.47 per share. | 08 Jan 2024 | 16,137,703 | 193,471,756 | - | 10.5 | 168,961,750 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.47 per share. | 08 Jan 2024 | 5,351,898 | 64,162,845 | - | 10.5 | 56,034,372 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Mr. Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 10.47 per share. | 08 Jan 2024 | 510,399 | 6,119,048 | - | 10.5 | 5,343,878 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 08 Jan 2024 | 10,000 | 329,978 | - | 42 | 420,000 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 22 Dec 2023 | 1,285 | 339,978 | - | 40 | 51,400 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 19 Dec 2023 | 500 | 169,724 | - | 1.6 | 815 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 19 Dec 2023 | 200 | 169,924 | - | 1.6 | 322 | Common Stock |
| RxSight Inc | Mr. Eric Weinberg | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.01 per share. | 15 Dec 2023 | 8,715 | 341,263 | - | 40.0 | 348,711 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 14 Dec 2023 | 900 | 169,224 | - | 1.5 | 1,368 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 14 Dec 2023 | 200 | 168,324 | - | 1.5 | 300 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 05 Dec 2023 | 600 | 167,724 | - | 1.4 | 834 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.36 per share. | 05 Dec 2023 | 324 | 168,124 | - | 1.4 | 441 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 05 Dec 2023 | 76 | 167,800 | - | 1.3 | 102 | Common Stock |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 29 Nov 2023 | 1,000 | 166,124 | - | 1.6 | 1,570 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 29 Nov 2023 | 1,000 | 167,124 | - | 1.5 | 1,530 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 22 Nov 2023 | 400 | 164,874 | - | 1.7 | 672 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 22 Nov 2023 | 250 | 165,124 | - | 1.8 | 445 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 20 Nov 2023 | 4,050 | 164,174 | - | 1.6 | 6,480 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 20 Nov 2023 | 300 | 164,474 | - | 1.6 | 468 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Nov 2023 | 1,800 | 160,124 | - | 1.5 | 2,772 | - |
| SILO Pharma Inc | Mr. Eric Weisblum | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 16 Nov 2023 | 1,100 | 158,324 | - | 1.3 | 1,463 | - |